Sign in
4

Changes in Ownership

MAXCYTE, INC. Filed Acc 0001209191-23-037358

President and CEO sold 43,851 shares at an average $5.04 ($220,859)

  • President and CEO acquired 43,851 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doerfler Douglas President and CEO 2023-06-13 Option exercise 10b5-1 +14,968 $0.04 $599 348,165 D: show line 1 in the form
Doerfler Douglas President and CEO 2023-06-13 Sale 10b5-1 −14,968 $5.03 $75,289 333,197 D: show line 2 in the form
Doerfler Douglas President and CEO 2023-06-14 Option exercise 10b5-1 +28,883 $0.04 $1,155 362,080 D: show line 3 in the form
Doerfler Douglas President and CEO 2023-06-14 Sale 10b5-1 −28,883 $5.04 $145,570 333,197 D: show line 4 in the form
Open-market sales · 43,851 sh · avg $5.04 · $220,859

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doerfler Douglas President and CEO 2023-06-13 Option exercise · Employee Stock Option (right to buy) 10b5-1 −14,968 293,963 D: show line 5 in the form
Doerfler Douglas President and CEO 2023-06-14 Option exercise · Employee Stock Option (right to buy) 10b5-1 −28,883 265,080 D: show line 6 in the form
Loading xslF345X04/doc4.xml…